Study on Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Acute Myeloid Leukemia (AML) That Has Returned or Not Responded to Treatment | Clinical Trial

Study on Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Acute Myeloid Leukemia (AML) That Has Returned or Not Responded to Treatment | Clinical Trial | Right2Hope